Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 33, 2005, Pages 5151-5155

  Toiyama, Yuji ^a   Mizoguchi, Akira ^a   Kimura, Kazushi ^a   Araki, Toshimitsu ^a   Yoshiyama, Shigeyuki ^a   Sakaguchi, Kouhei ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene expression; Oligonucleotide array; Ulcerative colitis

Indexed keywords

AUTACOID; HOMEODOMAIN PROTEIN; POLYPEPTIDE; TRANSCRIPTION FACTOR IIB;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; GENETIC SELECTION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATIENT MONITORING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; ULCERATIVE COLITIS;

EID: 26244465892     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kinsner J, Shorter R. Infalmmatory Bowel disease, 5th edn. Lea & Febiger, Philadelphia, PA 1999
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
3. Hibi T, Ogata H, Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol 2002; 37: 409-417
4. Savkovic SD, Koutosouris A, Hecht G. Activation of NF-κB in the intestinal epithelial cells by enteropathogenic Escherichia Coli. Am J Physiol Cell Physiol 1997; 273: 1160-1167
5. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics 2000; 4: 1-11
6. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445-456
7. Uthoff SM, Eichenberger MR, Lewis RK, Fox MP, Hamilton CJ, McAuliffe TL, Grimes HL, Galandiuk S. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol 2001; 19: 803-810
8. Masuda H, Takahashi Y, Asai S, Takayama T. Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res 2003; 111: 85-90
9. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 4947: 1041-1048
10. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res 1999; 248: 1-9
11. Cillo C, Cantile M, Faiella A, Boncinelli E. Homeobox genes in normal and malignant cells. J Cell Physiol 2001; 188: 161-169
12. Vider BZ, Zimber A, Chastre E, Gespach C, Halperin M, Mashiah P, Yaniv A, Gazit A. Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. Biochem Biophys Res Commun 2000; 272: 513-518
13. Doerksen LF, Bhattacharya A, Kannan P, Pratt D, Tainsky MA. Functional interaction between RARE and an AP-2 binding site in the regulation of the human HOX A4 gene promotor. Nucleic Acids Res 1996; 24: 2849-2857
14. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99: 416-420
15. Ierardi E, Principi M, Francavilla R, Passaro S, Noviello F, Burattini O, Francavilla A. Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis. Dig Dis Sci 2001; 46: 1083-1087
16. Steingart RA, Heldenberg E, Pinhasov A, Brenneman DE, Fridkin M, Gozes I. A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes. Life Sci 2002; 71: 2543-2552
17. Black BL, Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 1998; 14: 167-196
18. Breitbart RE, Liang CS, Smoot LB, Laheru DA, Mahdavi V, Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 1993; 118: 1095-1106
19. Blaeser F, Ho N, Prywes R, Chatila TA. Ca(2+)-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem 2000; 275: 197-209
20. Han TH, Prywes R. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol Cell Biol 1995; 15: 2907-2915
21. Coso OA, Montaner S, Fromm C, Lacal JC, Prywes R, Teramoto H, Gutkind JS. Signaling from G protein-coupled receptors to the c-jun promoter involves the MEF2 transcription factor. Evidence for a novel c-jun amino-terminal kinase-independent pathway. J Biol Chem 1997; 272: 20691-20697
22. Clarke N, Arenzana N, Hai T, Minden A, Prywes R. Epidermal growth factor induction of the c-jun promoter by a Rac pathway. Mol Cell Biol 1998; 18: 1065-1073
23. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997; 386: 296-299
24. Shin HM, Han TH. CD28-mediated regulation of the c-jun promoter involves the MEF2 transcription factor in Jurkat T cells. Mol Immunol 1999; 36: 197-203
25. Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, Winoto A. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol Cell Biol 1995; 15: 6364-6376